肝癌介入治疗的疗效分析

Interventional therapies of live cancer

目的进一步探讨原发性肝癌介入治疗的远期疗效及影响因素。方法对2001年8月至2007年5月来我院就诊的78例行介入治疗的原发性肝癌患者进行随访和回顾性分析,对影响肝癌治疗的相关因素进行探讨。结果肝癌介入治疗的疗效与患者的年龄、身体状况、脏器功能情况以及肿瘤的形态学特征和血供密切相关,所以根据患者以上情况,选择介入治疗的合理时机、熟练的导管技术非常重要。结论介入化疗栓塞治疗原发性肝癌疗效肯定,延长了病人生存期,但尚有一些问题需进一步探讨。

Objective To discuss the effect of transcatheter arterial chemoembolization（TACE） in treating primary liver cancer.Methods Retrospectively analyzed the data of 78 patiens with primary liver cancer by treatment of transcatheter arterial chemoembolization from Augest 2001 to May,2007.And the related factors that affected treatment of liver cancer were discussed.Results Interventional treating effect for primary liver cancer was related to the age and body condition of patients and morphology character of tumour.So the choice of treating chance and operating technique were very important.Conclusion The TAE therapy is effective in treating primary hepatomas,which can prolong survival time of patients,however,there are still some problems that need to be investigated further.